RYZNEUTA

Full Title

{"sup": ["®", "®"], "br": [null, null, null], "#text": "These highlights do not include all the information needed to use RYZNEUTA \n safely and effectively. See full prescribing information for RYZNEUTA.\n \n \nRYZNEUTA \n (efbemalenograstim alfa-vuxw) injection, for subcutaneous use\n \nInitial U.S. Approval: 2023"}